Ladbury, C.; Hao, C.; Ruel, C.; Liu, J.; Glaser, S.; Amini, A.; Wong, J.; Paz, I.; Leong, L.; Morgan, R.;
et al. Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial. Cancers 2022, 14, 5000.
https://doi.org/10.3390/cancers14205000
AMA Style
Ladbury C, Hao C, Ruel C, Liu J, Glaser S, Amini A, Wong J, Paz I, Leong L, Morgan R,
et al. Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial. Cancers. 2022; 14(20):5000.
https://doi.org/10.3390/cancers14205000
Chicago/Turabian Style
Ladbury, Colton, Claire Hao, Christopher Ruel, Jason Liu, Scott Glaser, Arya Amini, Jeffrey Wong, Isaac Paz, Lucille Leong, Robert Morgan,
and et al. 2022. "Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial" Cancers 14, no. 20: 5000.
https://doi.org/10.3390/cancers14205000
APA Style
Ladbury, C., Hao, C., Ruel, C., Liu, J., Glaser, S., Amini, A., Wong, J., Paz, I., Leong, L., Morgan, R., Margolin, K., Shibata, S., Frankel, P., Somlo, G., & Dandapani, S.
(2022). Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial. Cancers, 14(20), 5000.
https://doi.org/10.3390/cancers14205000